83
Views
2
CrossRef citations to date
0
Altmetric
Research Article

In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia

, , , , , , , , , & show all
Pages 484-490 | Received 20 Oct 2009, Accepted 24 Feb 2010, Published online: 13 Oct 2010

REFERENCES

  • Lungarella G, Cavarra E, Lucattelli M, Martorana PA: The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol. 2008;40:1287–1296.
  • Abraham E: Neutrophils and acute lung injury. Crit Care Med. 2003;31:195–199.
  • Jenne DE: Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis. Am J Respir Crit Care Med. 1994;150:147–154.
  • Delclaux C, Delacourt C, D’Ortho MP, Boyer V, Lafuma C, Harf A: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol. 1996;14:288–295.
  • Shapiro SD: Neutrophil elastase: path clearer, pathogen killer, or just pathologic? Am J Respir Cell Mol Biol. 2002;26:266–268.
  • Lee WL, Downey GP: Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med. 2001;164:896–904.
  • Fischer BM, Voynow JA: Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol. 2002;26:447–452.
  • Snider GL: Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu Rev Med. 1989;40:411–429.
  • Kawabata K, Hagio T, Matsumoto S, Nakao S, Orita S, Aze Y, Ohno H: Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med. 2000;161:2013–2018.
  • Sakamaki F, Ishizaka A, Urano T, Sayama K, Nakamura H, Terashima T, Waki Y, Tasaka S, Hasegawa N, Sato K, Nakagawa N, Obata T, Kanazawa M: Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 1996;153:391–397.
  • Utsugi M, Ishizuka T, Hisada T, Shimizu Y, Dobashi K, Mori M: Acute respiratory failure associated with miliary tuberculosis successfully treated with sivelestat sodium hydrate. Intern Med. 2006;45:1069–1070.
  • Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi T, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M: Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478–486.
  • Marston BJ, Lipman HB, Breiman RF: Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. Arch Intern Med. 1994;154:2417–2422.
  • Stout JE, Sens K, Mietzner S, Obman A, Yu VL: Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. Int J Antimicrob Agents. 2005;25:302–307.
  • Trisolini R, Agli LL, Cancellieri A, Procaccio L, Candoli P, Alifano M, Patelli M: Bronchoalveolar lavage findings in severe community-acquired pneumonia due to Legionella pneumophila serogroup 1. Respir Med. 2004;98:1222–1226.
  • Friedman H, Yamamoto Y, Klein TW: Legionella pneumophila pathogenesis and immunity. Semin Pediatr Infect Dis. 2002;13:273–279.
  • Yanagihara K, Fukuda Y, Seki M, Izumikawa K, Miyazaki Y, Hirakata Y, Tsukamoto K, Yamada T, Kamihira S, Kohno S: Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia. Exp Lung Res. 2007;33:71–80.
  • Kakeya H, Ehara N, Fukushima K, Seki M, Izumikawa K, Yamamoto Y, Yanagihara K, Saito A, Kohno S: Severe Legionnaires’ disease successfully treated using a combination of fluoroquinolone, erythromycin, corticosteroid, and sivelestat. Intern Med. 2008;47:773–777.
  • Higa F, Shinzato T, Toyama M, Haranaga S, Furugen M, Tateyama M, Koide M, Saito A, Fujita J: Efficacy of pazufloxacin mesilate in Legionnaires’ disease: a case report and in vitro study of the isolate. J Infect Chemother. 2005;11:164–168.
  • Higa F, Akamine M, Haranaga S, Tohyama M, Shinzato T, Tateyama M, Koide M, Saito A, Fujita J: In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species. J Antimicrob Chemother. 2005;56:1053–1057.
  • Aoki S, Hirakata Y, Miyazaki Y, Izumikawa K, Yanagihara K, Tomono K, Yamada Y, Tashiro T, Kohno S, Kamihira S: Detection of Legionella DNA by PCR of whole-blood samples in a mouse model. J Med Microbiol. 2003;52:325–329.
  • Kaneko Y, Yanagihara K, Seki M, Kuroki M, Miyazaki Y, Hirakata Y, Mukae H, Tomono K, Kadota J, Kohno S: Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol. 2003;285:L847–L853.
  • Hagio T, Matsumoto S, Nakao S, Abiru T, Ohno H, Kawabata K: Elastase inhibition reduced death associated with acid aspiration-induced lung injury in hamsters. Eur J Pharmacol. 2004;488:173–180.
  • Edelstein PH, Shinzato T, Edelstein MA: BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. J Antimicrob Chemother. 2001;48:667–675.
  • Higa F, Arakaki N, Tateyama M, Koide M, Shinzato T, Kawakami K, Saito A: In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp. J Antimicrob Chemother. 2003;52:920–924.
  • Greene C, Taggart C, Lowe G, Gallagher P, McElvaney N, O’Neill S: Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia. J Infect Dis. 2003;188:769–776.
  • Carden D, Xiao F, Moak C, Willis BH, Robinson-Jackson S, Alexander S: Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol. 1998;275:385–392.
  • Dalhoff A: Immunomodulatory activities of fluoroquinolones. Infection. 2005;33:55–70.
  • Huang HC, Shieh CC, Yu WL, Cheng KC, Chen CC, Chang ST, Chuang YC: Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries. Respirology. 2008;13:47–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.